@dimerix.com
Dimerix is a clinical-stage biopharmaceutical company, with a portfolio of drug candidates for inflammatory diseases, including kidney and respiratory diseases.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Logo
PNG
Icon
PNG
About
Description
Dimerix is a clinical-stage biopharmaceutical company, with a focus on developing patient-preferred pharmaceutical products for global markets. The company utilizes its proprietary platform technology called Receptor-HIT to identify and develop drugs in areas with unmet medical needs. Incorporated in 2004, Dimerix has made significant strides in the identification of a novel treatment, DMX-200, which has the potential to transform the lives of patients with inflammatory diseases, such as kidney or lung diseases.
Dimerix encourages collaboration and is open to partnering and product development discussions. The company values respect, honesty, commitment, and reliability, ensuring that its employees are delivering the best possible outcomes to themselves, their colleagues, investors, and business associates. Dimerix is committed to integrating environmental, social, and governance considerations across its development cycle, demonstrating a values-led culture.
With a highly experienced management team and board, Dimerix has the expertise and passion to advance new therapies and address unmet medical needs. Contact them today to learn more about their innovative solutions
Company Type
Public Company
Company Size
2-10
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories